PanGen Biotech Inc (222110) — Working Capital to Net Assets Ratio
PanGen Biotech Inc (222110) has a Working Capital to Net Assets ratio of 68.6% as of September 2025. Working capital of ₩20.60 Billion (current assets of ₩23.34 Billion minus current liabilities of ₩2.74 Billion) is measured against net assets of ₩30.03 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 222110 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
PanGen Biotech Inc Working Capital to Net Assets (2014–2024)
This chart shows how PanGen Biotech Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 68.6%, reflecting working capital of ₩20.60 Billion against net assets of ₩30.03 Billion KRW. See 222110 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for PanGen Biotech Inc (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for PanGen Biotech Inc from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see PanGen Biotech Inc market capitalisation.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 71.7% | ₩17.87 Billion | ₩24.91 Billion | ₩20.77 Billion | ₩2.90 Billion | ▲ +38.9 pp |
| 2023 | 32.9% | ₩4.13 Billion | ₩12.57 Billion | ₩9.84 Billion | ₩5.71 Billion | ▼ -10.4 pp |
| 2022 | 43.2% | ₩7.45 Billion | ₩17.22 Billion | ₩8.58 Billion | ₩1.13 Billion | ▼ -10.2 pp |
| 2021 | 53.4% | ₩11.27 Billion | ₩21.10 Billion | ₩31.15 Billion | ₩19.89 Billion | ▲ +25.3 pp |
| 2020 | 28.2% | ₩4.00 Billion | ₩14.21 Billion | ₩24.09 Billion | ₩20.09 Billion | ▼ -8.2 pp |
| 2019 | 36.4% | ₩6.70 Billion | ₩18.43 Billion | ₩25.61 Billion | ₩18.91 Billion | ▼ -13.5 pp |
| 2018 | 49.9% | ₩13.44 Billion | ₩26.94 Billion | ₩30.87 Billion | ₩17.43 Billion | ▲ +3.2 pp |
| 2017 | 46.7% | ₩14.61 Billion | ₩31.31 Billion | ₩17.91 Billion | ₩3.29 Billion | ▼ -2.9 pp |
| 2016 | 49.6% | ₩17.51 Billion | ₩35.31 Billion | ₩18.70 Billion | ₩1.19 Billion | ▲ +113.5 pp |
| 2015 | -63.9% | ₩-4.19 Billion | ₩6.56 Billion | ₩1.77 Billion | ₩5.96 Billion | ▼ -72.8 pp |
| 2014 | 8.9% | ₩951.54 Million | ₩10.69 Billion | ₩4.03 Billion | ₩3.08 Billion | — |